We are live on ! Find out more
NYLIM

New York Life Investment Management Portfolio holdings

AUM $14.3B
1-Year Est. Return 34.42%
This Fund
S&P 500
This Quarter Est. Return
+11.74%
1 Year Est. Return
+34.42%
3 Year Est. Return
+100.17%
5 Year Est. Return
+116.66%
10 Year Est. Return
+182.12%
AUM
$10.7B
AUM Growth
+$866M
Cap. Flow
-$4.29M
Cap. Flow %
-0.04%
Top 10 Hldgs %
28.81%
Holding
858
New
40
Increased
441
Reduced
309
Closed
60

Sector Composition

Rank Sector Weight
1 Technology 24.82%
2 Financials 10.16%
3 Consumer Discretionary 7.88%
4 Communication Services 7.07%
5 Healthcare 6.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNSL icon
626
Kinsale Capital Group
KNSL
$8.5B
$1.12M 0.01%
+2,316
New +$1.08M
FN icon
627
Fabrinet
FN
$20.9B
$1.12M 0.01%
+3,791
New +$845K
TAP icon
628
Molson Coors Class B
TAP
$7.83B
$1.11M 0.01%
22,994
-359
-2% -$19.8K
WYNN icon
629
Wynn Resorts
WYNN
$10.6B
$1.11M 0.01%
11,798
-21
-0.2% -$1.78K
ARMK icon
630
Aramark
ARMK
$16.2B
$1.1M 0.01%
26,377
-609
-2% -$22.6K
MRVL icon
631
Marvell Technology
MRVL
$206B
$1.09M 0.01%
14,076
-342
-2% -$21.3K
APG icon
632
APi Group
APG
$18.8B
$1.09M 0.01%
31,986
-558
-2% -$16K
QGEN icon
633
Qiagen
QGEN
$8.93B
$1.09M 0.01%
22,613
-476
-2% -$20.7K
FARO
634
DELISTED
Faro Technologies
FARO
$1.09M 0.01%
+24,706
New +$904K
SNX icon
635
TD Synnex
SNX
$20.6B
$1.05M 0.01%
7,766
-290
-4% -$34K
PARA
636
DELISTED
Paramount Global Class B
PARA
$1.04M 0.01%
80,760
+2,263
+3% +$26.5K
EXAS
637
DELISTED
Exact Sciences
EXAS
$1.03M 0.01%
19,340
-374
-2% -$19K
AOS icon
638
A.O. Smith
AOS
$8.45B
$1.02M 0.01%
15,601
-13,039
-46% -$853K
KD icon
639
Kyndryl
KD
$2.89B
$1.02M 0.01%
24,345
-516
-2% -$18.7K
MTCH icon
640
Match Group
MTCH
$8.4B
$1.02M 0.01%
32,914
-219
-0.7% -$6.55K
TTEK icon
641
Tetra Tech
TTEK
$9.12B
$1.01M 0.01%
28,013
-607
-2% -$20.2K
RRX icon
642
Regal Rexnord
RRX
$11.5B
$1.01M 0.01%
6,941
-149
-2% -$18.7K
AES icon
643
AES
AES
$10.5B
$1.01M 0.01%
95,543
+1,721
+2% +$18.4K
PLNT icon
644
Planet Fitness
PLNT
$3.63B
$1M 0.01%
9,214
-337
-4% -$33.7K
CUBE icon
645
CubeSmart
CUBE
$9.39B
$1M 0.01%
23,604
-545
-2% -$22.6K
BLD
646
DELISTED
TopBuild
BLD
$990K 0.01%
3,058
-100
-3% -$29.7K
WTRG icon
647
Essential Utilities
WTRG
$11.5B
$989K 0.01%
26,620
-3,939
-13% -$153K
WING icon
648
Wingstop
WING
$3.08B
$981K 0.01%
2,913
-207
-7% -$61.3K
FOX icon
649
Fox Class B
FOX
$24.1B
$975K 0.01%
18,887
+285
+2% +$13.9K
WBS icon
650
Webster Financial
WBS
$12.8B
$975K 0.01%
17,850
-412
-2% -$20.5K

Similar funds

New York Life Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, New York Life Investment Management held 858 positions worth $10.7B, up 8.8% from $9.82B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

New York Life Investment Management's Q2 2025 filing shows 40 new, 441 increased, 309 reduced and 60 closed positions. Its largest new stake was Franklin Senior Loan ETF: 2,612,190 shares worth $63.3M. The largest sale was Invesco DB US Dollar Index Bullish Fund, an estimated $43.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • New York Life Investment Management's largest Q2 2025 buy was Franklin Senior Loan ETF: 2,612,190 shares worth $63.3M.
  • New York Life Investment Management added most to Vanguard FTSE Developed Markets ETF in Q2 2025, an estimated $35.7M increase.
  • New York Life Investment Management's biggest Q2 2025 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $29.5M.
  • New York Life Investment Management fully exited Invesco DB US Dollar Index Bullish Fund in Q2 2025, selling an estimated $43.7M.
  • New York Life Investment Management's ten largest holdings make up 29% of its $10.7B portfolio in Q2 2025.
  • New York Life Investment Management opened 40 new positions and closed 60 in Q2 2025.
  • New York Life Investment Management's portfolio value rose 8.8% quarter-over-quarter to $10.7B.

Based on New York Life Investment Management's 13F filing for Q2 2025, filed 1 Aug 2025.